British Journal of Anaesthesia, 2001, Vol. 87, No. 4 549-558
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Anaphylaxis during anaesthesia. Results of a two-year survey in France
1Département d’Anesthésie-réanimation, CHU de Nancy, Hôpital Central, 29 Avenue de Lattre de Tassigny, F-54035 Nancy Cedex, France. 2Laboratoire d’Explorations Fonctionnelles Respiratoires et Allergologiques, CHU-Hopital Maison Blanche, F-51092 Reims, France*Corresponding author
Between January 1, 1997 and December 31, 1998, 467 patients were referred to one of the allergo-anaesthesia centres of the French GERAP (Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques) network and were diagnosed as having anaphylaxis during anaesthesia. Diagnosis was established on the basis of clinical history, skin tests and/or a specific IgE assay. The most frequent cause of anaphylaxis was a neuromuscular blocking agent (69.2%). Latex was less frequently incriminated (12.1%) than in previous reports. A significant difference was observed between the incidence of anaphylactic reactions observed with each neuromuscular blocking agent and the number of patients who received each drug during anaesthesia in France throughout the study period (P<0.0001). Succinylcholine and rocuronium were most frequently incriminated. Clinical reactions to neuromuscular blocking drugs were more severe than to latex. The diagnostic value of specific IgE assays was confirmed. These results are consistent with changes in the epidemiology of anaphylaxis related to anaesthesia and are an incentive for the further development of allergo-anaesthesia clinical networks.
Br J Anaesth 2001; 87: 549–58
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. W. Parkes, N. Harper, A. Herwadkar, and R. Pumphrey Anaphylaxis to the chlorhexidine component of Instillagel(R): a case series Br. J. Anaesth., January 1, 2009; 102(1): 65 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Habre, A. Adamicza, E. Lele, T. Novak, P. D. Sly, and F. Petak The Involvement of Histaminic and Muscarinic Receptors in the Bronchoconstriction Induced by Myorelaxant Administration in Sensitized Rabbits Anesth. Analg., December 1, 2008; 107(6): 1899 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schummer, M. Wirsing, and W. Schummer The Pivotal Role of Vasopressin in Refractory Anaphylactic Shock Anesth. Analg., August 1, 2008; 107(2): 620 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Mertes, A. B. Guttormsen, T. Harboe, S. G. O. Johansson, E. Florvaag, B. Husum, L. H. Garvey, M. Kroigaard, L. Gramstad, K. T. Kvande, et al. Can Spontaneous Adverse Event Reporting Systems Really Be Used to Compare Rates of Adverse Events Between Drugs? Anesth. Analg., February 1, 2007; 104(2): 471 - 472. [Full Text] [PDF]
|
|
|
|
|
|
F. Petak, Z. Hantos, A. Adamicza, H. Gality, and W. Habre Development of bronchoconstriction after administration of muscle relaxants in rabbits with normal or hyperreactive airways. Anesth. Analg., July 1, 2006; 103(1): 103 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Barbara, M.-C. Santais, D. A. Levy, F. Ruff, and F. Leynadier Prevention of latex sensitization in guinea pigs by a bacterial and viral filter used in anaesthesia Br. J. Anaesth., September 1, 2005; 95(3): 349 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Bhananker, J. T. O'Donnell, J. R. Salemi, and M. J. Bishop The Risk of Anaphylactic Reactions to Rocuronium in the United States Is Comparable to That of Vecuronium: An Analysis of Food and Drug Administration Reporting of Adverse Events Anesth. Analg., September 1, 2005; 101(3): 819 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Mertes, M. C. Laxenaire, J. M. Malinovsky, E. Florvaag, and D. A. Moneret-Vautrin Skin Sensitivity to Rocuronium and Vecuronium: Prick-Tests Are Not Intradermal Test Anesth. Analg., May 1, 2005; 100(5): 1539 - 1539. [Full Text] [PDF]
|
|
|
|
|
|
A. D. Axon and J. M. Hunter Editorial III: Anaphylaxis and anaesthesia--all clear now? Br. J. Anaesth., October 1, 2004; 93(4): 501 - 504. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Gilbar and A. M Ridge Inappropriate labelling of patients as opioid allergic Journal of Oncology Pharmacy Practice, September 1, 2004; 10(3): 177 - 182. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Hepner and M. C. Castells Anaphylaxis During the Perioperative Period Anesth. Analg., November 1, 2003; 97(5): 1381 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Brock-Utne, D. L. Hepner, and M. C. Castells Clinical Manifestations of Latex Anaphylaxis During Anesthesia Differ from Those Not Anesthesia/Surgery-Related * Response Anesth. Analg., October 1, 2003; 97(4): 1204 - 1205. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Hepner and M. C. Castells Latex Allergy: An Update Anesth. Analg., April 1, 2003; 96(4): 1219 - 1229. [Full Text] [PDF]
|
|